Total Outflow of High-Density Lipoprotein-Cholesteryl Esters from Plasma Is Decreased in a Model of 3/4 Renal Mass

María Luna-Luna1, Martha Franco2, Elizabeth Carreón-Torres1

  • 1Department of Molecular Biology, Instituto Nacional de Cardiologia "Ignacio Chavez", Mexico City 14080, Mexico.

Insights

Reduced kidney function in rabbits led to higher cholesteryl esters in high-density lipoproteins (HDL). This suggests kidneys play a role in regulating HDL lipid content and cholesterol homeostasis.

Area of Science:

  • Nephrology
  • Lipid Metabolism
  • Cardiovascular Research

Background:

  • Previous studies suggest kidneys influence high-density lipoprotein (HDL) cholesterol homeostasis.
  • The precise role of renal function in lipoprotein metabolism remains debated.

Purpose of the Study:

  • To investigate the impact of reduced renal mass on HDL cholesteryl ester turnover.
  • To elucidate the kidney's role in regulating HDL lipid content.

Main Methods:

  • Characterized HDL subclasses in rabbits with 75% reduced renal mass (Ntx).
  • Studied plasma HDL cholesteryl ester kinetics using tritium labeling.
  • Analyzed cholesteryl ester exchange between HDL and VLDL/LDL.

Main Results:

  • Reduced renal mass resulted in cholesteryl ester enrichment in HDL subclasses.
  • Cholesteryl ester exchange between HDL and apo B-lipoproteins was unchanged.
  • A decreased fractional catabolic rate (FCR) of HDL cholesteryl esters was observed in Ntx rabbits.

Conclusions:

  • Kidney mass reduction alters HDL lipid composition.
  • The kidneys' reduced capacity to catabolize HDL cholesteryl esters contributes to their accumulation.
  • Findings support a role for the kidneys in cholesterol homeostasis via HDL metabolism.

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
41
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
213
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels01:31

Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels

Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
238
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667
Three-Compartment Open Model01:06

Three-Compartment Open Model

The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
231
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
98